Rethinking the Cost-Benefit of PSA Tests

Was this Fixing U.S. Healthcare blog wrong to single out PSA as not worth its cost? This was the claim in two previous posts, including the overall most popular one, The Problem of Diminishing Marginal Benefit in Healthcare. Some new information suggests that we need to rethink that original claim. Prostate Specific Antigen Since prostate … Continue reading Rethinking the Cost-Benefit of PSA Tests